Parkinson's Disease Trial, Recruiting NCT07351032 Sponsor: McGill University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07351032
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of idiopathic Parkinson's disease (a form of Parkinson's not caused by another condition)
  • People who do not experience "freezing of gait" (sudden episodes where a person feels their feet are stuck to the ground), confirmed by a questionnaire and a movement test
  • People who have no other neurological (brain or nervous system) diagnoses
  • People who do not have a serious bone, joint, or balance condition that affects the way they walk or their ability to stay steady
  • People whose results on a standard memory and thinking test (the Montreal Cognitive Assessment) score 25 or higher, indicating no signs of mild cognitive impairment
  • People who are able to walk on their own, without any walking aids, for 30 minutes
  • People who have never used a split-belt treadmill before (a special treadmill where each foot moves at a different speed)

Who may not be able to join:

  • People who experience severe involuntary movements (dyskinesia) that interfere with walking or balance, or who have significant hearing or vision problems
  • People who are observed to be unable to walk safely on a standard treadmill during assessment
  • People who have a neurological condition other than Parkinson's disease, or another condition such as an orthopaedic (bone or joint) problem that affects their ability to move around
  • People who have a deep brain stimulator implanted (a device surgically placed in the brain to help manage Parkinson's symptoms)
  • People for whom transcranial magnetic stimulation (a non-invasive brain stimulation technique used in the trial) is not considered safe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Caroline Paquette, PhD, McGill University

Phone: 514-398-2488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University
Registry
ClinicalTrials.gov
Start date
18 November 2025
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Stride length; Dual Support

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov